Irinotecan is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. This product is available for immediate shipment nationwide.
Bedford Laboratories will supply irinotecan HCl injection as a sterile aqueous solution available in two different dosages including 40mg/2ml single dose amber vials individually boxed and 100mg/5ml single dose amber vials individually boxed.